When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about ...

While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more convenient option: A pill. Novo Nordisk already makes semaglutide ...

Danish drugmaker Novo Nordisk on Wednesday posted another quarter of rapid profit growth, though the story for once wasn’t its wildly popular weight-loss drugs. Novo Nordisk said its fourth ...

Lastly, the pharmaceutical giant has a solid dividend program, making it a good target for income-seeking investors. In short, Novo Nordisk is a solid long-term pick. Prosper Junior Bakiny has ...

Novo Nordisk (NVO), a pharmaceutical company, isn’t too worried about the U.S. government’s plan to negotiate prices for its popular diabetes and weight loss medicines, including Wegovy and ...